We analyzed the relationship between TFAP2 family proteins and the clinical stage of bladder cancer patients, and found that TFAP2C protein was positively correlated with the worse clinical stage of patients, while TFAP2B showed the opposite trend (Figure 1b). The gene discussed is TFAP2A; the disease is urinary bladder cancer.